 | • レポートコード：MRC2303I0096 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の皮膚科用デバイス市場規模が、予測期間中（2022年〜2027年）に年平均12.3%で成長すると予測しています。本レポートは、皮膚科用デバイスの世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、診断用デバイス別（イメージングデバイス、皮膚内視鏡、マイクロスコープ、皮膚鏡、その他）分析、治療用デバイス別（光治療器、レーザー、電気外科用機器、脂肪吸引装置、マイクロダーマブレーションデバイス）分析、治療用デバイス用途別（血管病変、ニキビ/乾癬/タトゥー除去、脱毛、シワ取り、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、Abbvie Inc. (Allergan Inc.)、Alma Lasers Ltd、Bausch Health Companies Inc. (Solta Medical Inc.)、Bruker Corporation、CANDELA CORPORATION、Carl Zeiss、Cutera Inc.、Galderma SA、Genesis Biosystems Inc.、Hologic Inc. (Cynosure Inc.)、Lumenis Ltd、Merz Pharma GmbH & Co. KGaAなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の皮膚科用デバイス市場規模：診断用デバイス別 - イメージングデバイスの市場規模 - 皮膚内視鏡の市場規模 - マイクロスコープの市場規模 - 皮膚鏡の市場規模 - その他診断用デバイスの市場規模 ・世界の皮膚科用デバイス市場規模：治療用デバイス別 - 光治療器の市場規模 - レーザーの市場規模 - 電気外科用機器の市場規模 - 脂肪吸引装置の市場規模 - マイクロダーマブレーションデバイスの市場規模 ・世界の皮膚科用デバイス市場規模：治療用デバイス用途別 - 血管病変用デバイスの市場規模 - ニキビ/乾癬/タトゥー除去用デバイスの市場規模 - 脱毛用デバイスの市場規模 - シワ取り用デバイスの市場規模 - その他用途の皮膚科用デバイス市場規模 ・世界の皮膚科用デバイス市場規模：地域別 - 北米の皮膚科用デバイス市場規模 アメリカの皮膚科用デバイス市場規模 カナダの皮膚科用デバイス市場規模 メキシコの皮膚科用デバイス市場規模 … - ヨーロッパの皮膚科用デバイス市場規模 ドイツの皮膚科用デバイス市場規模 イギリスの皮膚科用デバイス市場規模 フランスの皮膚科用デバイス市場規模 … - アジア太平洋の皮膚科用デバイス市場規模 中国の皮膚科用デバイス市場規模 日本の皮膚科用デバイス市場規模 インドの皮膚科用デバイス市場規模 … - 中東/南米の皮膚科用デバイス市場規模 南アフリカの皮膚科用デバイス市場規模 ブラジルの皮膚科用デバイス市場規模 アルゼンチンの皮膚科用デバイス市場規模 … - その他地域の皮膚科用デバイス市場規模 ・競争状況 ・市場機会・将来の動向 |
The Dermatology Devices Market is expected to register a CAGR of 12.3% during the forecast period (2022-2027).
The outbreak of the COVID-19 pandemic significantly impacted the dermatology devices market. The closure of non-essential businesses disrupted the dermatology industry. According to a survey by Hamilton Fraser Cosmetic Insurance, conducted in March 2020 with 1,360 cosmetic practitioners in the United Kingdom to assess the impact of the pandemic on cosmetic procedures, stated that 99.78% of practitioners revealed that their practice was affected during the current pandemic. Thus, COVID-19 significantly impacted the growth rate of the market over the pandemic phase, although, with the upliftment of the lockdowns and the resumption of cosmetic treatments globally, the market is expected to show growth over time.
Factors such as the growing geriatric population, increasing awareness about aesthetic procedures, and technological advancements in dermatology devices are expected to propel the growth of the market.
The growing number of aesthetic procedures performed across the world also creates the need for dermatological devices and hence drives the growth of the market. For instance, according to the International Society of Plastic Surgeons report released in December 2021, the total number of aesthetic/cosmetic procedures performed in the year 2020 worldwide for breast augmentation were 1,624,281, liposuction (1,525,197), eyelid surgery (1,225,540), rhinoplasty (852,554), and abdominoplasty (765,248). Furthermore, the launch of technologically advanced products is also propelling the growth of the market. For instance, in December 2021, Obagi, a science-based skincare company and one of the leaders in professional skincare products, launched the Skintrinsiq device and made its entry into the complementary skincare device market. Obagi is one of the first professional skincare companies to design and develop a professional-use facial device offering an advanced delivery system for Obagi’s transformational products.
Additionally, the strategic initiatives taken by the market players and approvals for the products are also boosting the growth of the market. For instance, in June 2022, Casio Computer Co., Ltd. issued an EU Declaration of Conformity regarding the DZ-D100 dermatology camera and DZ-S50 dermatology scope after the completion of conformity studies for European Medical Device Regulations (MDR). It also reported that the DZ-D100 and DZ-S50 are expected to launch in Europe in August 2022 and are scheduled to be sold by Casio Europe GmbH (Norderstedt, Germany) and Casio Electronics Co. Ltd. (Wembley, UK). Such initiatives are expected to have a positive impact on the growth of the market.
Thus, owing to the abovementioned factors, the market is expected to have significant growth over the forecast period. However, the side effects related to dermatological treatments and stringent regulatory policies for medical devices may hamper the growth of the market over the analysis period.
Dermatology Devices Market Trends
Wrinkle Removal Segment is Anticipated to Show High Growth Over the Forecast Period
The wrinkle removal segment is expected to project significant growth over the forecast period owing to factors such as the growing burden of the elderly and geriatric population, and increasing awareness about aesthetic procedures coupled with the launch and approval of the products.
The growing geriatric population is also boosting the growth of the market segment. For instance, as per the Statistics Canada 2021 census, there were around 7,021,430 people aged 65 years or above, out of which 3,224,680 were males and 3,796,750 were females, living in Canada in 2021. Such a rise in the geriatric and elderly population ultimately results in facial aging, leading to wrinkles, thereby boosting the demand for these devices.
Additionally, the launch of wrinkle removal devices based on advanced technology in the country is also contributing to the growth of the segment. For instance, in January 2022, Lumenis launched the Splendor X device into the United Kingdom market. The device has already received a CE mark for hair removal, vascular treatments, pigmented lesions, and the treatment of wrinkles. The system is powered by BLEND X technology, which emits a binary laser at synchronized and controllable ratios of Nd: YAG (1064 nm) and Alexandrite (755 nm) wavelengths. Such launches are expected to propel the growth of the market segment. Furthermore, in April 2021, Crown Aesthetics, a division of Crown Laboratories, Inc., received United States Food and Drug Administration (FDA) clearance for SkinPen Precision for the treatment of wrinkles on the neck. Such approvals are also expected to boost the growth of the market segment.
Thus, owing to the abovementioned factors, the market segment is expected to project growth over the forecast period.
North American Region Holds the Largest Market Share of Dermatology Devices Market
North America accounted for the major share of the market studied. This trend is likely to continue due to the increasing prevalence of skin cancer and other skin diseases, such as eczema and rosacea, coupled with approval for dermatological devices and increasing awareness about aesthetic procedures.
According to the American Cancer Society’s 2022 statistics, in the United States, an estimated 99,780 new cases of melanoma of the skin are expected to be reported in 2022. Of those, 57,180 cases are likely to be registered among males and 42,600 in females. Thus, the rising burden of skin cancer and other skin diseases is a major contributor to the increasing demand for dermatology devices, thus boosting the growth of the market.
Moreover, several medical technology companies focus on products that deliver less expensive, quicker, and more efficient patient care. For instance, in July 2020, Lancer Skincare launched the Pro Polish Microdermabrasion Device. Pro Polish enhances the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device. These advancements in dermatology devices, in terms of features and wide-scale application for skin diseases, are expected to bolster the demand for dermatology devices in the region. Additionally, in June 2020, AbbVie Inc. (Allergan Aesthetics) received the United States Food and Drug Administration approval for JUVÉDERM VOLUMA XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. Such approvals are also boosting the growth of the market.
Thus, owing to the abovementioned factors, the studied market is expected to project considerable growth over the forecast period in North America.
Dermatology Devices Market Competitor Analysis
The dermatology devices market is moderately competitive. The market players are expanding the dermatology devices portfolio by improving their existing product portfolios with continuous innovation in the devices that are already available in the market. The players are also adopting growth strategies to expand their product offerings, strengthen their geographical reach, and increase their customer base. Some of the major players include Cutera Inc., Hologic Inc. (Cynosure Inc.), Lumenis Ltd., Alma Lasers, Candela Corporation, and others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Incidences of Skin Disorders
4.2.2 Technological Advancements in Skin Care Devices
4.2.3 Increasing Awareness on Aesthetic Procedures
4.3 Market Restraints
4.3.1 Side Effects Related To Dermatological Treatments
4.3.2 Stringent Regulatory Policies for Medical Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Diagnostic Devices Type
5.1.1 Imaging Devices
5.1.2 Dermatoscopes
5.1.3 Microscopes
5.2 By Diagnostic Devices Application
5.2.1 Skin Cancer Diagnosis
5.2.2 Other Diagnostic Device Applications
5.3 By Treatment Devices Type
5.3.1 Light Therapy Devices
5.3.2 Lasers
5.3.3 Electrosurgical Equipment
5.3.4 Liposuction Devices
5.3.5 Microdermabrasion Devices
5.3.6 Cryotherapy Devices
5.4 By Treatment Devices Application
5.4.1 Vascular Lesions
5.4.2 Acne, Psoriasis, and Tattoo Removal
5.4.3 Hair Removal
5.4.4 Wrinkle Removal
5.4.5 Body Contouring and Fat Removal
5.4.6 Other Treatment Device Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia Pacific
5.5.4 Middle East
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbvie Inc. (Allergan Inc.)
6.1.2 Alma Lasers Ltd
6.1.3 Bausch Health Companies Inc. (Solta Medical Inc.)
6.1.4 Bruker Corporation
6.1.5 CANDELA CORPORATION
6.1.6 Carl Zeiss
6.1.7 Cutera Inc.
6.1.8 Galderma SA
6.1.9 Genesis Biosystems Inc.
6.1.10 Hologic Inc. (Cynosure Inc.)
6.1.11 Lumenis Ltd
6.1.12 Merz Pharma GmbH & Co. KGaA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS